Matches in Wikidata for { <http://www.wikidata.org/entity/Q98898098> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q98898098 description "article scientifique publié en 2020" @default.
- Q98898098 description "artículu científicu espublizáu n'agostu de 2020" @default.
- Q98898098 description "im August 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q98898098 description "scientific article published on 31 August 2020" @default.
- Q98898098 description "wetenschappelijk artikel" @default.
- Q98898098 description "наукова стаття, опублікована 31 серпня 2020" @default.
- Q98898098 name "Comparison of Dapaglifozin and Liraglutide in patients with poorly controlled type 2 Diabetes Mellitus: a 24-week, Open, Double-centered, Head to Head Trial" @default.
- Q98898098 name "Comparison of Dapaglifozin and Liraglutide in patients with poorly controlled type 2 Diabetes Mellitus: a 24-week, Open, Double-centered, Head to Head Trial" @default.
- Q98898098 type Item @default.
- Q98898098 label "Comparison of Dapaglifozin and Liraglutide in patients with poorly controlled type 2 Diabetes Mellitus: a 24-week, Open, Double-centered, Head to Head Trial" @default.
- Q98898098 label "Comparison of Dapaglifozin and Liraglutide in patients with poorly controlled type 2 Diabetes Mellitus: a 24-week, Open, Double-centered, Head to Head Trial" @default.
- Q98898098 prefLabel "Comparison of Dapaglifozin and Liraglutide in patients with poorly controlled type 2 Diabetes Mellitus: a 24-week, Open, Double-centered, Head to Head Trial" @default.
- Q98898098 prefLabel "Comparison of Dapaglifozin and Liraglutide in patients with poorly controlled type 2 Diabetes Mellitus: a 24-week, Open, Double-centered, Head to Head Trial" @default.
- Q98898098 P1433 Q98898098-4B12E49F-0CDD-4B91-B097-F452F64CC9BA @default.
- Q98898098 P1476 Q98898098-E6CEA4A1-7621-4D0F-9F1C-A5F228E77D8A @default.
- Q98898098 P2093 Q98898098-9193ED5E-EB4F-461B-9DDD-1542797DF5E0 @default.
- Q98898098 P2093 Q98898098-BC8B3DF9-EE0D-4817-B2A5-B2B1C4CFE1F5 @default.
- Q98898098 P2093 Q98898098-E66571C0-B341-47CB-9896-F8CEDAC01BF4 @default.
- Q98898098 P31 Q98898098-2C679C9A-5BC0-4183-845C-4A951FEE4B8C @default.
- Q98898098 P356 Q98898098-07DB5DB8-F07B-4F4D-89EA-9BCD0F1BB78A @default.
- Q98898098 P577 Q98898098-E34D6C0D-AA3A-4D06-8563-1CB24CA10304 @default.
- Q98898098 P698 Q98898098-C6284921-4069-4939-A9A8-6DEB1AF5800C @default.
- Q98898098 P921 Q98898098-4ACC1BBA-80A5-48F2-BD07-C940A7969B98 @default.
- Q98898098 P921 Q98898098-5D916FEC-D594-4C49-A74F-8CF49DA82E21 @default.
- Q98898098 P356 1871530320999200831165116 @default.
- Q98898098 P698 32875989 @default.
- Q98898098 P1433 Q26842338 @default.
- Q98898098 P1476 "Comparison of Dapaglifozin and Liraglutide in patients with poorly controlled type 2 Diabetes Mellitus: a 24-week, Open, Double-centered, Head to Head Trial" @default.
- Q98898098 P2093 "Jianjia Jiang" @default.
- Q98898098 P2093 "Lu Lin" @default.
- Q98898098 P2093 "Pin Chen" @default.
- Q98898098 P31 Q13442814 @default.
- Q98898098 P356 "10.2174/1871530320999200831165116" @default.
- Q98898098 P577 "2020-08-31T00:00:00Z" @default.
- Q98898098 P698 "32875989" @default.
- Q98898098 P921 Q2526479 @default.
- Q98898098 P921 Q3025883 @default.